How country-specific should a country-specific cost-effectiveness analysis be?

@article{Reed2013HowCS,
  title={How country-specific should a country-specific cost-effectiveness analysis be?},
  author={Shelby D Reed},
  journal={European heart journal},
  year={2013},
  volume={34 3},
  pages={166-7}
}
Two recent cost-effectiveness analyses published in the European Heart Journal add to a growing evidence base regarding the costs and health outcomes associated with dabigatran vs. warfarin for patients with atrial fibrillation and ticagrelor vs. clopidogrel for patients with acute coronary syndromes. Conducted from the perspective of the Swedish healthcare system, both analyses are trial-based economic evaluations augmented with decision models to extrapolate short-term trial outcomes to… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 14 references

Similar Papers

Loading similar papers…